Treatment of early-onset multiple sclerosis with intramuscular interferonβ-1a: long-term results
Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Angelo Ghezzi, Lucia Moiola(Vita-Salute San Raffaele University), Vittorio Martinelli(Vita-Salute San Raffaele University), Maria Giovanna Marrosu(University of Cagliari), María Trojano(University of Bari Aldo Moro), Maria Pia Amato(University of Florence), Paolo Gallo(University of Padua), Francesco Patti(University of Catania), Marco Capobianco(Ospedale San Luigi Gonzaga), Carlo Pozzilli(Sapienza University of Rome), C. Milanese(Fondazione IRCCS Istituto Neurologico Carlo Besta), Giancarlo Comi(University of Milan), N. Milani(Fondazione Istituto Neurologico Nazionale Casimiro Mondino)
Cited by 65
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
Multiple Sclerosis Severity Score
|Neurology|2005|959